PHASE 2 RANDOMIZED TRIAL COMPARING STANDARD RCHOP VERSUS BRCAP AS FIRST LINE TREATMENT IN YOUNG PATIENTS WITH HIGH-RISK DLBCL. A STUDY FROM SPANISH GROUP GELTAMO
| Autor: | Santiago Mercadal, Alejandro Martín, Isidro Jarque, Armando López-Guillermo, Juan-Manuel Sancho, Carlos Grande, Javier Lopez, Francisco-Javier Peñalver, J. Bargay, Carmen Albo, Maria J. Rodriguez-Salazar, Santiago Montes-Moreno, Concepción Nicolás, Estrella Carrillo, Jose Maria Roncero, Miguel Canales, Mónica Coronado, Eva González-Barca, José-Ángel Hernández, Luis Palomera, Eulogio Conde, Dolores Caballero, María José Ramírez, J. Perez De Oteyza |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Cancer Research
medicine.medical_specialty business.industry Hematology General Medicine law.invention First line treatment 03 medical and health sciences 0302 clinical medicine Oncology Randomized controlled trial law Group (periodic table) 030220 oncology & carcinogenesis Internal medicine Physical therapy medicine business 030215 immunology |
| Zdroj: | Hematological Oncology. 35:188-189 |
| ISSN: | 0278-0232 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text